|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61P 27/02 | (2006.01) |
| (11) | Number of the document | 4185318 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22728724.0 |
| Date of filing the European patent application | 2022-05-16 | |
| (97) | Date of publication of the European application | 2023-05-31 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-03 |
| (46) | Date of publication of the claims translation | 2025-11-10 |
| (86) | Number | PCT/US2022/029462 |
| Date | 2022-05-16 |
| (87) | Number | WO 2022/245739 |
| Date | 2022-11-24 |
| (30) | Number | Date | Country code |
| 202163189541 P | 2021-05-17 | US | |
| 202163235398 P | 2021-08-20 | US | |
| 202263297420 P | 2022-01-07 | US | |
| 202263306315 P | 2022-02-03 | US |
| (72) |
VITTI, Robert L. , US
BERLINER, Alyson J. , US
CHU, Karen , US
ASMUS, Friedrich , DE
DA SILVA LEAL, Sergio Casimiro , CH
EISSING, Thomas , DE
RITTENHOUSE, Kay D. , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
Bayer HealthCare LLC , 100 Bayer Boulevard, Whippany, NJ 07981, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Prailginto atpalaidavimo, didelės dozės VEGF antagonisto režimai, skirti akių angiogeninių sutrikimų gydymui |
| EXTENDED, HIGH DOSE VEGF ANTAGONIST REGIMENS FOR TREATMENT OF ANGIOGENIC EYE DISORDERS |
| Payment date | Validity (years) | Amount | |
| 2026-04-21 | 5 | 115.00 EUR |
| 2027-05-16 |